Gotoh N - Search Results

1

Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.

Ishihara R, Oda T, Murakami Y, Matsumura I, Watanabe S, Asao Y, Masuda Y, Gotoh N, Kasamatsu T, Takei H, Kobayashi N, Sasaki N, Saitoh T, Murakami H, Handa H. Ishihara R, et al. Among authors: gotoh n. Int J Mol Sci. 2023 Jan 22;24(3):2216. doi: 10.3390/ijms24032216. Int J Mol Sci. 2023. PMID: 36768545 Free PMC article.

2

Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.

Kasamatsu T, Saitoh T, Ino R, Gotoh N, Mitsui T, Shimizu H, Matsumoto M, Sawamura M, Yokohama A, Handa H, Tsukamoto N, Murakami H. Kasamatsu T, et al. Among authors: gotoh n. Hematol Oncol. 2017 Dec;35(4):711-718. doi: 10.1002/hon.2322. Epub 2016 Jul 13. Hematol Oncol. 2017. PMID: 27405747

3

The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP.

Takahashi N, Saitoh T, Gotoh N, Nitta Y, Alkebsi L, Kasamatsu T, Minato Y, Yokohama A, Tsukamoto N, Handa H, Murakami H. Takahashi N, et al. Among authors: gotoh n. BMC Immunol. 2017 May 16;18(1):26. doi: 10.1186/s12865-017-0210-3. BMC Immunol. 2017. PMID: 28511637 Free PMC article.

4

IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma.

Kasamatsu T, Kimoto M, Takahashi N, Minato Y, Gotoh N, Takizawa M, Matsumoto M, Sawamura M, Yokohama A, Handa H, Tsukamoto N, Saitoh T, Murakami H. Kasamatsu T, et al. Among authors: gotoh n. Hematol Oncol. 2018 Feb;36(1):196-201. doi: 10.1002/hon.2469. Epub 2017 Aug 7. Hematol Oncol. 2018. PMID: 28786198

5

PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia.

Kasamatsu T, Ino R, Takahashi N, Gotoh N, Minato Y, Takizawa M, Yokohama A, Handa H, Saitoh T, Tsukamoto N, Murakami H. Kasamatsu T, et al. Among authors: gotoh n. Br J Haematol. 2018 Mar;180(5):705-714. doi: 10.1111/bjh.15085. Epub 2018 Jan 23. Br J Haematol. 2018. PMID: 29359792 Free article.

6

Short-term administration of recombinant human erythropoietin decreases B cell number in human peripheral blood.

Nagashima T, Yokohama A, Nagai K, Kasamatsu T, Gotoh N, Iriuchishima H, Sekigami T, Saitoh T, Handa H, Tsukamoto N, Murakami H. Nagashima T, et al. Among authors: gotoh n. Transfus Apher Sci. 2018 Apr;57(2):208-214. doi: 10.1016/j.transci.2018.01.009. Epub 2018 Feb 2. Transfus Apher Sci. 2018. PMID: 29439918

7

Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.

Gotoh N, Saitoh T, Takahashi N, Kasamatsu T, Minato Y, Lobna A, Oda T, Hoshino T, Sakura T, Shimizu H, Takizawa M, Handa H, Yokohama A, Tsukamoto N, Murakami H. Gotoh N, et al. Int J Hematol. 2018 Sep;108(3):246-253. doi: 10.1007/s12185-018-2464-9. Epub 2018 May 8. Int J Hematol. 2018. PMID: 29737460

8

PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.

Kasamatsu T, Awata M, Ishihara R, Murakami Y, Gotoh N, Matsumoto M, Sawamura M, Yokohama A, Handa H, Tsukamoto N, Saitoh T, Murakami H. Kasamatsu T, et al. Among authors: gotoh n. Clin Exp Med. 2020 Feb;20(1):51-62. doi: 10.1007/s10238-019-00585-4. Epub 2019 Oct 16. Clin Exp Med. 2020. PMID: 31620907

9

PARP1 V762A polymorphism affects the prognosis of myelodysplastic syndromes.

Gotoh N, Minato Y, Saitoh T, Takahashi N, Kasamatsu T, Souma K, Oda T, Hoshino T, Sakura T, Ishizaki T, Shimizu H, Takizawa M, Yokohama A, Tsukamoto N, Handa H, Murakami H. Gotoh N, et al. Eur J Haematol. 2020 Jun;104(6):526-537. doi: 10.1111/ejh.13393. Epub 2020 Mar 4. Eur J Haematol. 2020. PMID: 32003046

10

DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway.

Oda T, Nakamura R, Kasamatsu T, Gotoh N, Okuda K, Saitoh T, Handa H, Murakami H, Yamashita T. Oda T, et al. Among authors: gotoh n. Cancer Gene Ther. 2022 Feb;29(2):225-240. doi: 10.1038/s41417-021-00302-y. Epub 2021 Feb 22. Cancer Gene Ther. 2022. PMID: 33619341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page